(Q66407729)
Statements
AVERTS-2 (English)
0 references
A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter, Phase 3 Study of OTO-104 Given as a Single Intratympanic Injection in Subjects With Unilateral Meniere's Disease (English)
0 references
21 March 2016
0 references
31 August 2017
0 references
176
0 references
18 year
0 references
85 year
0 references